COR Stock Recent News
COR LATEST HEADLINES
Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 7, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Fin.
The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, COR, JBL and KLAC hold promise.
VANCOUVER, BC / ACCESS Newswire / March 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (" Camino " or the " Company ") is pleased to provide an update on its previously announced 1 acquisition (the " Proposed Transaction ") of all of the issued and outstanding shares of Cuprum Resources Chile SpA (" Cuprum "), which owns the construction-ready Puquios copper project located in Chile (the " Puquios Project "). The Company is pleased to announce that it has filed an independent technical report (the " Puquios Project Technical Report ") entitled " Puquios Project - NI 43-101 Technical Report and Pre-feasibilityStudy, La Higuera, Coquimbo Region, Chile " with respect to the Puquios Project, which is expected to be one of the Company's principal material properties for the purposes of Canadian securities laws upon completion of the Proposed Transaction.
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.